En vigueur

Tramadol excretion study administered orally for the improvement of detection of these substances in anti-doping controls (clinical part)

Investigateur principal
R. de la Torre
Pays
Espagne
Institution
Institut Municipal d’Investigacio Medica (IMIM)
Année approuvée
2022
Statut
En vigueur

Description du projet

Code: T22M01RTRV - Part 1

Salbutamolwas included in the prohibited list of the World Anti-Doping Agency (WADA) in 2004. While systemic salbutamol is banned, inhaled salbutamol is permitted but with dosage regimen restrictions. The dose should indeed not exceed “1600 µg over 24 hours in divided doses not to exceed 800 µg over.